Terug
Dagbereik
€ 33,03
€ 34,87
52-Weeksbereik
€ 20,85
€ 54,85
Volume
634.468
50D / 200D Gem.
€ 44,58
/
€ 40,45
Vorige Slotkoers
€ 33,28
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -246,3 | 0,4 |
| P/B | 24,1 | 2,9 |
| ROE % | -8,4 | 3,7 |
| Net Margin % | -1,9 | 3,9 |
| Rev Growth 5Y % | 39,2 | 10,0 |
| D/E | 4,8 | 0,2 |
Koersdoel Analisten
Hold
€ 74,25
+118.4%
Low: € 63,00
High: € 94,00
Forward K/W
46,7
Forward WPA
€ 0,73
WPA Groei (sch.)
+0,0%
Omzet Sch.
370 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 8,79
€ 8,13 – € 9,96
|
1,1 B | 1 |
| FY2029 |
€ 7,31
€ 6,76 – € 8,28
|
970 M | 1 |
| FY2028 |
€ 4,13
€ 2,92 – € 5,34
|
740 M | 2 |
Belangrijkste Punten
Revenue grew 39,22% annually over 5 years — strong growth
Debt/Equity of 4,80 — high leverage
Generating 42,98M in free cash flow
Capital efficient — spends only 0,33% of revenue on capex
Interest coverage of 1,51× — tight debt servicing
Groei
Revenue Growth (5Y)
39,22%
Revenue (1Y)36,41%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-8,42%
ROIC8,97%
Net Margin-1,89%
Op. Margin13,37%
Veiligheid
Debt / Equity
4,80
Current Ratio2,20
Interest Coverage1,51
Waardering
P/E Ratio
-246,31
P/B Ratio24,14
EV/EBITDA39,69
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 36,41% | Revenue Growth (3Y) | 44,62% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 39,22% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 272,30M | Net Income (TTM) | -5,14M |
| ROE | -8,42% | ROA | -1,29% |
| Gross Margin | 75,05% | Operating Margin | 13,37% |
| Net Margin | -1,89% | Free Cash Flow (TTM) | 42,98M |
| ROIC | 8,97% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 4,80 | Current Ratio | 2,20 |
| Interest Coverage | 1,51 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -246,31 | P/B Ratio | 24,14 |
| P/S Ratio | 4,65 | PEG Ratio | 4,91 |
| EV/EBITDA | 39,69 | Dividend Yield | 0,00% |
| Market Cap | 1,27B | Enterprise Value | 1,44B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 272,30M | 199,61M | 130,19M | 88,60M | 72,48M |
| Net Income | -5,14M | -17,48M | -24,41M | -14,09M | -18,01M |
| EPS (Diluted) | -0,14 | -0,49 | -0,75 | -0,51 | -0,69 |
| Gross Profit | 204,37M | 150,37M | 90,55M | 63,21M | 54,26M |
| Operating Income | 36,40M | 8,82M | 431.000,0 | 1,92M | 1,61M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 399,48M | 388,97M | 311,76M | 157,38M | 98,33M |
| Total Liabilities | 347,39M | 319,67M | 241,75M | 130,14M | 87,40M |
| Shareholders' Equity | 52,45M | 69,65M | 70,36M | 27,60M | 11,29M |
| Total Debt | 251,98M | 228,83M | 190,50M | 112,23M | 77,96M |
| Cash & Equivalents | 72,93M | 47,25M | 74,09M | 96,27M | 42,17M |
| Current Assets | 211,75M | 189,65M | 139,07M | 118,26M | 60,66M |
| Current Liabilities | 96,30M | 91,34M | 49,34M | 18,63M | 9,72M |